Abiopharma

Net Asset Value(s)

The trustees report for the series during the period from 1.1.25 to 1.4.25 - Mishmeret

Gilead - European Commission Approves Trodelvy® as a First-Line Treatment for Metastatic Triple-Negative Breast Cancer Patients Not Candidates for PD-(l)1 Inhibitors

European Commission Approves Trodelvy® as a First-Line Treatment for Metastatic Triple-Negative Breast Cancer Patients Not Candidates for PD-(l)1 Inhibitors

Trucker Path Leverages Verisk CargoNet Data to Help Drivers Identify High-Risk Cargo Theft Areas

Harvest déclare la distribution de juin 2026 de Société à capital scindé Grandes pharmaceutiques

Quantum Cyber Unveils Quantum Station: A Battlefield Operating System for Multi-Domain Autonomous Warfare

Regulatory Approvals Underscore Strength of NiSource’s Customer-Focused Data Center Strategy Supporting Growth in Indiana

XCharge Enters the Energy Storage Market and launches GridOne at EES Europe

Dragonfly Energy Appoints AI and Battery Technology Innovator Dr. Lukas Lutz to Board of Directors